Search results
The First Drug to Treat Desmoid Tumors Is Here
Verywell Health via Yahoo News· 4 months agoThe FDA approved Ogsiveo by drugmaker SpringWorks Therapeutics to manage desmoid tumors in adults—the first drug of its kind. The drug helps reduce the...
I had a benign tumor in my abdomen. I still needed chemo to make it smaller and now I'm infertile.
INSIDER via Yahoo News· 6 months agoPost-childbirth, she discovered a benign desmoid tumor in her abdomen. Undergoing chemotherapy for...
Doctors dismissed a 32-year-old's pain and fatigue as anxiety and weight for years. She had a rare...
INSIDER via Yahoo News· 1 year agoStephanie Clark now.Stephanie Clark For years, Stephanie Clark experienced pain, fatigue, strange...
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up
Zacks via Yahoo Finance· 3 months agoImmunome (IMNM) inks an asset purchase agreement with Ayala Pharmaceuticals to acquire the latter's...
McKesson (MCK) Announces Availability of FDA-Approved Drug
Zacks via Yahoo Finance· 4 months agoThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is...
SpringWorks Catapults 19% On A 'Watershed Moment' In Cancer Treatment
Investor's Business Daily· 5 months agoShares of SpringWorks Therapeutics rocketed Tuesday after U.S. regulators signed off on its new...
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal
Zacks via Yahoo Finance· 2 years agoSpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult...
US FDA approves SpringWorks Therapeutics' non-cancerous tumor treatment
Reuters via AOL· 5 months ago(Reuters) -The U.S. health regulator on Monday approved SpringWorks Therapeutics' drug for treating...
SpringWorks Therapeutics Shares Jump On HC Wainwright Bullish Pitch
Benzinga via Yahoo Finance· 2 years agoHC Wainwright points out that investors are enthusiastic about SpringWorks Therapeutics Inc (NASDAQ:...
Why SpringWorks Shares Are Soaring Today Premarket
Benzinga via Yahoo Finance· 2 years agoSpringWorks Therapeutics Inc (NASDAQ: SWTX) has announced positive topline results from the DeFi Phase 3 trial evaluating nirogacestat in adult patients...
